Skip to main content

Table 1 Metabolic assessment

From: Accelerated amyloid angiopathy and related vascular alterations in a mixed murine model of Alzheimer´s disease and type two diabetes

 

Body weight (g)

Glucose (mg/dl)

Insulin (ng/dl)

Control

28.50 ± 1.84

122.71 ± 9.58

0.75 ± 0.29

Control-HFD

44.50 ± 4.80††

114.00 ± 7.15

5.52 ± 2.28††

APP/PS1

28.61 ± 0.87

129.83 ± 4.20

0.69 ± 0.12

APP/PS1-HFD

42.95 ± 2.54††

118.17 ± 9.94

7.13 ± 0.99††

db/db

48.88 ± 2.83††

484.50 ± 33.73‡‡

6.90 ± 1.76††

APP/PS1xdb/db

42.87 ± 2.09††

448.40 ± 68.20‡‡

6.68 ± 2.08††

  1. Body weight [F(5,35) = 13.04, ††p < 0.01 vs. Control and APP/PS1] and insulin levels [F(5,44) = 5.32, ††p < 0.01 vs. Control and APP/PS1] were significantly increased in animals on HFD, db/db and APP/PS1xdb/db mice, while glucose levels were significantly higher in diabetic mice [F(5,39) = 52.19, ‡‡p < 0.01 vs. Control, Control-HFD, APP/PS1 and APP/PS1-HFD]. Data are representative of 5–12 mice (Control n = 7, Control-HFD n = 7, APP/PS1 n = 12, APP/PS1-HFD n = 6, db/db n = 8, APP/PS1xdb/db n = 5)